Novartis AG (NVSEF)
163.60
+5.99
(+3.80%)
USD |
OTCM |
Aug 24, 16:00
Novartis Price : 163.60 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 160.24 | 163.60 | 160.24 | 163.60 | 533.00 |
| Aug 21, 2026 | 157.61 | 157.61 | 157.61 | 157.61 | 62.00 |
| Aug 20, 2026 | 157.61 | 157.61 | 157.61 | 157.61 | 380.00 |
| Aug 19, 2026 | 160.00 | 160.00 | 160.00 | 160.00 | 2294.00 |
| Aug 18, 2026 | 149.73 | 149.73 | 149.73 | 149.73 | 169.00 |
| Aug 17, 2026 | 149.28 | 149.28 | 145.93 | 145.93 | 857.00 |
| Aug 14, 2026 | 157.90 | 157.90 | 157.90 | 157.90 | 89.00 |
| Aug 13, 2026 | 157.90 | 157.90 | 157.90 | 157.90 | 131.00 |
| Aug 12, 2026 | 157.90 | 157.90 | 157.90 | 157.90 | 146.00 |
| Aug 11, 2026 | 157.00 | 157.90 | 157.00 | 157.90 | 374.00 |
| Aug 10, 2026 | 151.42 | 151.42 | 151.42 | 151.42 | 4629.00 |
| Aug 07, 2026 | 151.92 | 151.92 | 151.92 | 151.92 | 753.00 |
| Aug 06, 2026 | 151.92 | 151.92 | 151.92 | 151.92 | 503.00 |
| Aug 05, 2026 | 151.92 | 151.92 | 151.92 | 151.92 | 96.00 |
| Aug 04, 2026 | 151.92 | 151.92 | 151.92 | 151.92 | 1989.00 |
| Aug 03, 2026 | 151.92 | 151.92 | 151.92 | 151.92 | 732.00 |
| Jul 31, 2026 | 158.52 | 158.52 | 158.52 | 158.52 | 328.00 |
| Jul 30, 2026 | 158.52 | 158.52 | 158.52 | 158.52 | 246.00 |
| Jul 29, 2026 | 158.52 | 158.52 | 158.52 | 158.52 | 675.00 |
| Jul 28, 2026 | 150.00 | 150.00 | 150.00 | 150.00 | 139.00 |
| Jul 27, 2026 | 150.00 | 150.00 | 150.00 | 150.00 | 376.00 |
| Jul 24, 2026 | 154.47 | 154.47 | 154.47 | 154.47 | 113.00 |
| Jul 23, 2026 | 152.56 | 154.47 | 152.56 | 154.47 | 390.00 |
| Jul 22, 2026 | 153.01 | 153.01 | 153.01 | 153.01 | 7249.00 |
| Jul 21, 2026 | 153.00 | 153.00 | 153.00 | 153.00 | 73.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Roche Holding AG | 57.47 |
| Addex Therapeutics Ltd. | 3.75 |
| Oculis Holding AG | 12.94 |
| Sandoz Group AG | 91.43 |
| Galderma Group AG | 42.49 |
Price Related Metrics
| PE Ratio | 24.69 |
| PS Ratio | 5.750 |
| Price to Book Value | 7.209 |
| Price to Free Cash Flow | 20.75 |
| Earnings Yield | 4.05% |
| Market Cap | 299.48B |
| Operating PE Ratio | 19.44 |
| Normalized PE Ratio | 23.00 |